Successful Use of Extended Criteria Donor Grafts With Low to Moderate Steatosis in Patients With Model for End-Stage Liver Disease Scores Below 27
Abstract Liver transplantation may be performed using extended criteria donor grafts (ECDg). The characteristics of ECDg include age >60 years, long intensive care unit (ICU) stay, history of malignancy or steatosis. Grafts are often discarded due to steatosis, which can be macrovesicular (MaS) o...
Gespeichert in:
Veröffentlicht in: | Transplantation proceedings 2009, Vol.41 (1), p.208-212 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 212 |
---|---|
container_issue | 1 |
container_start_page | 208 |
container_title | Transplantation proceedings |
container_volume | 41 |
creator | Avolio, A.W Frongillo, F Nicolotti, N Mulè, A Vennarecci, G De Simone, P Agnes, S |
description | Abstract Liver transplantation may be performed using extended criteria donor grafts (ECDg). The characteristics of ECDg include age >60 years, long intensive care unit (ICU) stay, history of malignancy or steatosis. Grafts are often discarded due to steatosis, which can be macrovesicular (MaS) or microvesicular (MiS). MaS is the variety most frequently involved with unfavorable outcomes due to primary nonfunction (PNF) or primary dysfunction (PDF). As of January 2000, all livers referred to our institution were considered potentially transplantable. Steatosis was defined as the presence of fat droplets in more than 5% of hepatocytes. We observed 35 steatotic grafts. Grafts were stratified according to MaS and MiS as follows: low steatosis (5%–15%), mild steatosis (16%–30%), moderate steatosis (31%–60%), or severe steatosis (>60%). Fifteen grafts with moderate (n = 2) or severe (n = 13) MaS were discarded. Twenty grafts were harvested: 18 of them were transplanted at our institution, the remaining 2, discarded by our donor team, were transplanted by other Italian centers. Low MaS was detected in 10 grafts (50%), mild MaS in 4 (20%), and moderate MaS in 2 (10%). Low MiS was detected in 8 grafts (40%), mild MiS in 5 (25%), and moderate MiS in 1 (5%). Steatotic grafts were transplanted only into recipients with model for end-stage liver disease (MELD) scores |
doi_str_mv | 10.1016/j.transproceed.2008.10.050 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66985150</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134508015509</els_id><sourcerecordid>66985150</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-2a487d37aa4faf10f021985f0b4869516cb9112563f4914fb42563c8bcaa5b303</originalsourceid><addsrcrecordid>eNqNkt2O0zAQhSMEYsvCKyALCe5S_JsmXCAtbVmQikAqKy4txxmDSxovHmd_XoMnxqFlhbjiyrbmmzP2OS6KZ4zOGWXVy908RTPgZQwWoJtzSutcmFNF7xUzVi9EySsu7hczSiUrmZDqpHiEuKP5zKV4WJywhstGMTUrfm5HawHRjT25QCDBkfVNgqGDjiyjTxC9IaswhEjOo3EJyRefvpFNuCYpkA-hg2gSkG0CkwJ6JH4gn0zyMPxBJ6YnLgush67cJvMVyMZfQSQrj2DyzK0NEZC8gT6r8sXj4oEzPcKT43paXLxdf16-Kzcfz98vzzallZVIJTeyXnRiYYx0xjHqKGdNrRxtZV3lx1W2bRjjqhJONky6Vk57W7fWGNUKKk6LFwfdbOSPETDpvUcLfW8GCCPqqspyTE3gqwNoY0CM4PRl9HsTbzWjekpE7_TfiegpkalGfzc_PU4Z232u3bUeI8jA8yNg0JreZSHr8Y7jjEvOZZ251YGD7MmVh6jRZpstdD6CTboL_v_u8_ofGdv7wefJ3-EWcBfGOGTXNdPINdXb6Q9NX4jWlClFG_ELl5_Fbw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66985150</pqid></control><display><type>article</type><title>Successful Use of Extended Criteria Donor Grafts With Low to Moderate Steatosis in Patients With Model for End-Stage Liver Disease Scores Below 27</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Avolio, A.W ; Frongillo, F ; Nicolotti, N ; Mulè, A ; Vennarecci, G ; De Simone, P ; Agnes, S</creator><creatorcontrib>Avolio, A.W ; Frongillo, F ; Nicolotti, N ; Mulè, A ; Vennarecci, G ; De Simone, P ; Agnes, S</creatorcontrib><description>Abstract Liver transplantation may be performed using extended criteria donor grafts (ECDg). The characteristics of ECDg include age >60 years, long intensive care unit (ICU) stay, history of malignancy or steatosis. Grafts are often discarded due to steatosis, which can be macrovesicular (MaS) or microvesicular (MiS). MaS is the variety most frequently involved with unfavorable outcomes due to primary nonfunction (PNF) or primary dysfunction (PDF). As of January 2000, all livers referred to our institution were considered potentially transplantable. Steatosis was defined as the presence of fat droplets in more than 5% of hepatocytes. We observed 35 steatotic grafts. Grafts were stratified according to MaS and MiS as follows: low steatosis (5%–15%), mild steatosis (16%–30%), moderate steatosis (31%–60%), or severe steatosis (>60%). Fifteen grafts with moderate (n = 2) or severe (n = 13) MaS were discarded. Twenty grafts were harvested: 18 of them were transplanted at our institution, the remaining 2, discarded by our donor team, were transplanted by other Italian centers. Low MaS was detected in 10 grafts (50%), mild MaS in 4 (20%), and moderate MaS in 2 (10%). Low MiS was detected in 8 grafts (40%), mild MiS in 5 (25%), and moderate MiS in 1 (5%). Steatotic grafts were transplanted only into recipients with model for end-stage liver disease (MELD) scores <27. The 6-month graft survival was 80%; the PNF rate was 10%; and the PDF rate was 15%. The careful use of ECDg with low to moderate steatosis is possible if particular care is taken to avoid additional risk factors related to the recipient.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2008.10.050</identifier><identifier>PMID: 19249515</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; Biopsy ; Fatty Liver - classification ; Fatty Liver - pathology ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Gastroenterology. Liver. Pancreas. Abdomen ; Graft Survival ; Humans ; Life Tables ; Liver Failure - surgery ; Liver Failure, Acute - surgery ; Liver Transplantation - mortality ; Liver Transplantation - physiology ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Medical sciences ; Middle Aged ; Other diseases. Semiology ; Patient Selection ; Reoperation ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Tissue Donors ; Tissue, organ and graft immunology ; Young Adult</subject><ispartof>Transplantation proceedings, 2009, Vol.41 (1), p.208-212</ispartof><rights>Elsevier Inc.</rights><rights>2009 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-2a487d37aa4faf10f021985f0b4869516cb9112563f4914fb42563c8bcaa5b303</citedby><cites>FETCH-LOGICAL-c463t-2a487d37aa4faf10f021985f0b4869516cb9112563f4914fb42563c8bcaa5b303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.transproceed.2008.10.050$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>310,311,315,782,786,791,792,3554,4028,4054,4055,23939,23940,25149,27932,27933,27934,46004</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21242248$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19249515$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Avolio, A.W</creatorcontrib><creatorcontrib>Frongillo, F</creatorcontrib><creatorcontrib>Nicolotti, N</creatorcontrib><creatorcontrib>Mulè, A</creatorcontrib><creatorcontrib>Vennarecci, G</creatorcontrib><creatorcontrib>De Simone, P</creatorcontrib><creatorcontrib>Agnes, S</creatorcontrib><title>Successful Use of Extended Criteria Donor Grafts With Low to Moderate Steatosis in Patients With Model for End-Stage Liver Disease Scores Below 27</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Abstract Liver transplantation may be performed using extended criteria donor grafts (ECDg). The characteristics of ECDg include age >60 years, long intensive care unit (ICU) stay, history of malignancy or steatosis. Grafts are often discarded due to steatosis, which can be macrovesicular (MaS) or microvesicular (MiS). MaS is the variety most frequently involved with unfavorable outcomes due to primary nonfunction (PNF) or primary dysfunction (PDF). As of January 2000, all livers referred to our institution were considered potentially transplantable. Steatosis was defined as the presence of fat droplets in more than 5% of hepatocytes. We observed 35 steatotic grafts. Grafts were stratified according to MaS and MiS as follows: low steatosis (5%–15%), mild steatosis (16%–30%), moderate steatosis (31%–60%), or severe steatosis (>60%). Fifteen grafts with moderate (n = 2) or severe (n = 13) MaS were discarded. Twenty grafts were harvested: 18 of them were transplanted at our institution, the remaining 2, discarded by our donor team, were transplanted by other Italian centers. Low MaS was detected in 10 grafts (50%), mild MaS in 4 (20%), and moderate MaS in 2 (10%). Low MiS was detected in 8 grafts (40%), mild MiS in 5 (25%), and moderate MiS in 1 (5%). Steatotic grafts were transplanted only into recipients with model for end-stage liver disease (MELD) scores <27. The 6-month graft survival was 80%; the PNF rate was 10%; and the PDF rate was 15%. The careful use of ECDg with low to moderate steatosis is possible if particular care is taken to avoid additional risk factors related to the recipient.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Fatty Liver - classification</subject><subject>Fatty Liver - pathology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Graft Survival</subject><subject>Humans</subject><subject>Life Tables</subject><subject>Liver Failure - surgery</subject><subject>Liver Failure, Acute - surgery</subject><subject>Liver Transplantation - mortality</subject><subject>Liver Transplantation - physiology</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Other diseases. Semiology</subject><subject>Patient Selection</subject><subject>Reoperation</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Tissue Donors</subject><subject>Tissue, organ and graft immunology</subject><subject>Young Adult</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkt2O0zAQhSMEYsvCKyALCe5S_JsmXCAtbVmQikAqKy4txxmDSxovHmd_XoMnxqFlhbjiyrbmmzP2OS6KZ4zOGWXVy908RTPgZQwWoJtzSutcmFNF7xUzVi9EySsu7hczSiUrmZDqpHiEuKP5zKV4WJywhstGMTUrfm5HawHRjT25QCDBkfVNgqGDjiyjTxC9IaswhEjOo3EJyRefvpFNuCYpkA-hg2gSkG0CkwJ6JH4gn0zyMPxBJ6YnLgush67cJvMVyMZfQSQrj2DyzK0NEZC8gT6r8sXj4oEzPcKT43paXLxdf16-Kzcfz98vzzallZVIJTeyXnRiYYx0xjHqKGdNrRxtZV3lx1W2bRjjqhJONky6Vk57W7fWGNUKKk6LFwfdbOSPETDpvUcLfW8GCCPqqspyTE3gqwNoY0CM4PRl9HsTbzWjekpE7_TfiegpkalGfzc_PU4Z232u3bUeI8jA8yNg0JreZSHr8Y7jjEvOZZ251YGD7MmVh6jRZpstdD6CTboL_v_u8_ofGdv7wefJ3-EWcBfGOGTXNdPINdXb6Q9NX4jWlClFG_ELl5_Fbw</recordid><startdate>2009</startdate><enddate>2009</enddate><creator>Avolio, A.W</creator><creator>Frongillo, F</creator><creator>Nicolotti, N</creator><creator>Mulè, A</creator><creator>Vennarecci, G</creator><creator>De Simone, P</creator><creator>Agnes, S</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2009</creationdate><title>Successful Use of Extended Criteria Donor Grafts With Low to Moderate Steatosis in Patients With Model for End-Stage Liver Disease Scores Below 27</title><author>Avolio, A.W ; Frongillo, F ; Nicolotti, N ; Mulè, A ; Vennarecci, G ; De Simone, P ; Agnes, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-2a487d37aa4faf10f021985f0b4869516cb9112563f4914fb42563c8bcaa5b303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Fatty Liver - classification</topic><topic>Fatty Liver - pathology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Graft Survival</topic><topic>Humans</topic><topic>Life Tables</topic><topic>Liver Failure - surgery</topic><topic>Liver Failure, Acute - surgery</topic><topic>Liver Transplantation - mortality</topic><topic>Liver Transplantation - physiology</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Other diseases. Semiology</topic><topic>Patient Selection</topic><topic>Reoperation</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Tissue Donors</topic><topic>Tissue, organ and graft immunology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Avolio, A.W</creatorcontrib><creatorcontrib>Frongillo, F</creatorcontrib><creatorcontrib>Nicolotti, N</creatorcontrib><creatorcontrib>Mulè, A</creatorcontrib><creatorcontrib>Vennarecci, G</creatorcontrib><creatorcontrib>De Simone, P</creatorcontrib><creatorcontrib>Agnes, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Avolio, A.W</au><au>Frongillo, F</au><au>Nicolotti, N</au><au>Mulè, A</au><au>Vennarecci, G</au><au>De Simone, P</au><au>Agnes, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful Use of Extended Criteria Donor Grafts With Low to Moderate Steatosis in Patients With Model for End-Stage Liver Disease Scores Below 27</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2009</date><risdate>2009</risdate><volume>41</volume><issue>1</issue><spage>208</spage><epage>212</epage><pages>208-212</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><abstract>Abstract Liver transplantation may be performed using extended criteria donor grafts (ECDg). The characteristics of ECDg include age >60 years, long intensive care unit (ICU) stay, history of malignancy or steatosis. Grafts are often discarded due to steatosis, which can be macrovesicular (MaS) or microvesicular (MiS). MaS is the variety most frequently involved with unfavorable outcomes due to primary nonfunction (PNF) or primary dysfunction (PDF). As of January 2000, all livers referred to our institution were considered potentially transplantable. Steatosis was defined as the presence of fat droplets in more than 5% of hepatocytes. We observed 35 steatotic grafts. Grafts were stratified according to MaS and MiS as follows: low steatosis (5%–15%), mild steatosis (16%–30%), moderate steatosis (31%–60%), or severe steatosis (>60%). Fifteen grafts with moderate (n = 2) or severe (n = 13) MaS were discarded. Twenty grafts were harvested: 18 of them were transplanted at our institution, the remaining 2, discarded by our donor team, were transplanted by other Italian centers. Low MaS was detected in 10 grafts (50%), mild MaS in 4 (20%), and moderate MaS in 2 (10%). Low MiS was detected in 8 grafts (40%), mild MiS in 5 (25%), and moderate MiS in 1 (5%). Steatotic grafts were transplanted only into recipients with model for end-stage liver disease (MELD) scores <27. The 6-month graft survival was 80%; the PNF rate was 10%; and the PDF rate was 15%. The careful use of ECDg with low to moderate steatosis is possible if particular care is taken to avoid additional risk factors related to the recipient.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>19249515</pmid><doi>10.1016/j.transproceed.2008.10.050</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-1345 |
ispartof | Transplantation proceedings, 2009, Vol.41 (1), p.208-212 |
issn | 0041-1345 1873-2623 |
language | eng |
recordid | cdi_proquest_miscellaneous_66985150 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Adult Biological and medical sciences Biopsy Fatty Liver - classification Fatty Liver - pathology Fundamental and applied biological sciences. Psychology Fundamental immunology Gastroenterology. Liver. Pancreas. Abdomen Graft Survival Humans Life Tables Liver Failure - surgery Liver Failure, Acute - surgery Liver Transplantation - mortality Liver Transplantation - physiology Liver. Biliary tract. Portal circulation. Exocrine pancreas Medical sciences Middle Aged Other diseases. Semiology Patient Selection Reoperation Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Tissue Donors Tissue, organ and graft immunology Young Adult |
title | Successful Use of Extended Criteria Donor Grafts With Low to Moderate Steatosis in Patients With Model for End-Stage Liver Disease Scores Below 27 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T10%3A59%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20Use%20of%20Extended%20Criteria%20Donor%20Grafts%20With%20Low%20to%20Moderate%20Steatosis%20in%20Patients%20With%20Model%20for%20End-Stage%20Liver%20Disease%20Scores%20Below%2027&rft.jtitle=Transplantation%20proceedings&rft.au=Avolio,%20A.W&rft.date=2009&rft.volume=41&rft.issue=1&rft.spage=208&rft.epage=212&rft.pages=208-212&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/j.transproceed.2008.10.050&rft_dat=%3Cproquest_cross%3E66985150%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66985150&rft_id=info:pmid/19249515&rft_els_id=S0041134508015509&rfr_iscdi=true |